Summary:
Florida Lung Asthma and Sleep Specialists is conducting a Randomized , Paralle 1 Group, Placebo Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticaone Propinate 100ug and Salmeterol Xinafoate 50/ug Inhalation Powder Compared with Advair Diskus 100/50 in subjects with Asthma
Qualified Participants Must:
• Be between 12 and 75 years of age
•
Be diagnosed with asthma
Qualified Participants May Receive:
Study related office visits at no cost and compensation for time and travel.